{"id":32406,"date":"2024-09-06T12:12:31","date_gmt":"2024-09-06T16:12:31","guid":{"rendered":"https:\/\/www.cancerresearch.org\/?post_type=cri_news&#038;p=32406"},"modified":"2024-09-06T12:15:43","modified_gmt":"2024-09-06T16:15:43","slug":"global-experts-converge-at-cicon24-to-unveil-groundbreaking-advances-in-cancer-immunotherapy-september-8-11-2024-at-national-harbor-md","status":"publish","type":"cri_news","link":"https:\/\/www.cancerresearch.org\/es\/media-room\/global-experts-converge-at-cicon24-to-unveil-groundbreaking-advances-in-cancer-immunotherapy-september-8-11-2024-at-national-harbor-md","title":{"rendered":"Global Experts Converge at CICON24 to Unveil Groundbreaking Advances in Cancer Immunotherapy, September 8-11, 2024 at National Harbor, MD"},"content":{"rendered":"\n<p><strong>NATIONAL HARBOR, MD<\/strong> \u2013 The Cancer Research Institute (CRI) and the European Network for Cancer Immunotherapy (ENCI) are hosting the Eighth International Cancer Immunotherapy Conference (CICON24), taking place September 8-11, 2024, at the Gaylord National Resort and Convention Center in National Harbor, Maryland.\u00a0<\/p>\n\n\n\n<p>CICON24 is an unparalleled event in cancer immunology, bringing together the world\u2019s leading experts to explore groundbreaking research and innovations that are reshaping the future of cancer treatment. Keynote speaker<strong> Cathy Wu, MD<\/strong>, from Dana-Farber Cancer Institute, will unveil cutting-edge advancements in personalized cancer vaccines, while esteemed leaders like <strong>Elizabeth Jaffee, MD<\/strong>, from Johns Hopkins Medicine, and <strong>Dana Pe\u2019er, PhD<\/strong>, from Memorial Sloan Kettering Cancer Center will dive deep into neoadjuvant immunotherapy and multiomic data analysis. Pe\u2019er will also lead a pivotal panel on how new tools and technologies are driving immuno-oncology breakthroughs and the challenges to implementing them.&nbsp;<\/p>\n\n\n\n<p>Attendees will experience a rich program of transformative science, featuring proffered talks, plenaries, and poster sessions. Pioneers like <strong>Luis Diaz, MD<\/strong>, of Memorial Sloan Kettering, and <strong>Wolf Herv\u00e9 Fridman, MD<\/strong>, from Cordeliers Research Center, Paris, will discuss innovative approaches to making pancreatic cancer immune-responsive and the critical role of tertiary lymphoid aggregates in anti-cancer immunity. CICON24\u2019s diverse agenda covers topics ranging from metabolic pathways to the impact of diet and the microbiome on cancer treatment, offering something for everyone.&nbsp;<\/p>\n\n\n\n<p>Beyond the science, CICON24 provides unparalleled opportunities to network with top researchers, clinicians, and industry leaders from across the globe. Whether you&#8217;re building your career as a postdoctoral fellow or a seasoned cancer researcher, this conference is your chance to form collaborations and spark ideas that could drive the next major breakthrough in cancer immunotherapy. Join us in National Harbor and be part of a global movement translating science into survival.&nbsp;<\/p>\n\n\n\n<p><strong>Register Today<\/strong>: Register today for CICON24 and be part of this groundbreaking event. Online registration closes on September 7, 2024. Go to <a href=\"https:\/\/www.cancerimmunotherapyconference.org\/\" target=\"_blank\" rel=\"noreferrer noopener\"><strong>www.cancerimmunotherapyconference.org<\/strong><\/a><strong> <\/strong>for full details. &nbsp;<\/p>\n\n\n\n<p><strong>Press Information:<\/strong> Press members can email Dustin Etheridge, Director of Communications for CRI, at <a href=\"mailto:detheridge@cancerresearch.org\" target=\"_blank\" rel=\"noreferrer noopener\">detheridge@cancerresearch.org<\/a> for credentials. <strong>*Confirmed members of the media will be invited to exclusive interview opportunities with three of the leading voices at CICON24.&nbsp;<\/strong>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>NATIONAL HARBOR, MD \u2013 The Cancer Research Institute (CRI) and the European Network for Cancer Immunotherapy (ENCI) are hosting the Eighth International Cancer Immunotherapy Conference (CICON24), taking place September 8-11, 2024, at [&hellip;]<\/p>\n","protected":false},"featured_media":32407,"template":"","tags":[18,28,37,101],"resource_cancer_types":[],"resource_patient_age":[],"resource_cancer_stage":[],"resource_treatment_type":[],"resource_treatment_status":[],"class_list":["post-32406","cri_news","type-cri_news","status-publish","has-post-thumbnail","hentry","tag-cancer-awareness","tag-cicon","tag-conferences","tag-patient-education"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Global Experts Converge at CICON24 to Unveil Groundbreaking Advances in Cancer Immunotherapy, September 8-11, 2024 at National Harbor, MD - Cancer Research Institute<\/title>\n<meta name=\"description\" content=\"CRI is co-hosting CICON24 to illuminate pioneering advances in cancer immunotherapy research starting September 8 in National Harbor, MD.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.cancerresearch.org\/media-room\/global-experts-converge-at-cicon24-to-unveil-groundbreaking-advances-in-cancer-immunotherapy-september-8-11-2024-at-national-harbor-md\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Global Experts Converge at CICON24 to Unveil Groundbreaking Advances in Cancer Immunotherapy, September 8-11, 2024 at National Harbor, MD - Cancer Research Institute\" \/>\n<meta property=\"og:description\" content=\"CRI is co-hosting CICON24 to illuminate pioneering advances in cancer immunotherapy research starting September 8 in National Harbor, MD.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.cancerresearch.org\/media-room\/global-experts-converge-at-cicon24-to-unveil-groundbreaking-advances-in-cancer-immunotherapy-september-8-11-2024-at-national-harbor-md\" \/>\n<meta property=\"og:site_name\" content=\"Cancer Research Institute\" \/>\n<meta property=\"article:modified_time\" content=\"2024-09-06T16:15:43+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2024\/09\/457019805_892139226283858_8428744184134729690_n-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"1080\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.cancerresearch.org\/media-room\/global-experts-converge-at-cicon24-to-unveil-groundbreaking-advances-in-cancer-immunotherapy-september-8-11-2024-at-national-harbor-md\",\"url\":\"https:\/\/www.cancerresearch.org\/media-room\/global-experts-converge-at-cicon24-to-unveil-groundbreaking-advances-in-cancer-immunotherapy-september-8-11-2024-at-national-harbor-md\",\"name\":\"Global Experts Converge at CICON24 to Unveil Groundbreaking Advances in Cancer Immunotherapy, September 8-11, 2024 at National Harbor, MD - Cancer Research Institute\",\"isPartOf\":{\"@id\":\"https:\/\/www.cancerresearch.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.cancerresearch.org\/media-room\/global-experts-converge-at-cicon24-to-unveil-groundbreaking-advances-in-cancer-immunotherapy-september-8-11-2024-at-national-harbor-md#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.cancerresearch.org\/media-room\/global-experts-converge-at-cicon24-to-unveil-groundbreaking-advances-in-cancer-immunotherapy-september-8-11-2024-at-national-harbor-md#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2024\/09\/457019805_892139226283858_8428744184134729690_n-1.jpg\",\"datePublished\":\"2024-09-06T16:12:31+00:00\",\"dateModified\":\"2024-09-06T16:15:43+00:00\",\"description\":\"CRI is co-hosting CICON24 to illuminate pioneering advances in cancer immunotherapy research starting September 8 in National Harbor, MD.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.cancerresearch.org\/media-room\/global-experts-converge-at-cicon24-to-unveil-groundbreaking-advances-in-cancer-immunotherapy-september-8-11-2024-at-national-harbor-md#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.cancerresearch.org\/media-room\/global-experts-converge-at-cicon24-to-unveil-groundbreaking-advances-in-cancer-immunotherapy-september-8-11-2024-at-national-harbor-md\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.cancerresearch.org\/media-room\/global-experts-converge-at-cicon24-to-unveil-groundbreaking-advances-in-cancer-immunotherapy-september-8-11-2024-at-national-harbor-md#primaryimage\",\"url\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2024\/09\/457019805_892139226283858_8428744184134729690_n-1.jpg\",\"contentUrl\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2024\/09\/457019805_892139226283858_8428744184134729690_n-1.jpg\",\"width\":1080,\"height\":1080},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.cancerresearch.org\/media-room\/global-experts-converge-at-cicon24-to-unveil-groundbreaking-advances-in-cancer-immunotherapy-september-8-11-2024-at-national-harbor-md#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.cancerresearch.org\/es\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Media Room Article\",\"item\":\"https:\/\/www.cancerresearch.org\/media-room\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Global Experts Converge at CICON24 to Unveil Groundbreaking Advances in Cancer Immunotherapy, September 8-11, 2024 at National Harbor, MD\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.cancerresearch.org\/#website\",\"url\":\"https:\/\/www.cancerresearch.org\/\",\"name\":\"Cancer Research Institute\",\"description\":\"For a World Immune to Cancer\",\"publisher\":{\"@id\":\"https:\/\/www.cancerresearch.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.cancerresearch.org\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.cancerresearch.org\/#organization\",\"name\":\"Cancer Research Institute\",\"url\":\"https:\/\/www.cancerresearch.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.cancerresearch.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/05\/logo-gradient.svg\",\"contentUrl\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/05\/logo-gradient.svg\",\"width\":156,\"height\":53,\"caption\":\"Cancer Research Institute\"},\"image\":{\"@id\":\"https:\/\/www.cancerresearch.org\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Global Experts Converge at CICON24 to Unveil Groundbreaking Advances in Cancer Immunotherapy, September 8-11, 2024 at National Harbor, MD - Cancer Research Institute","description":"CRI is co-hosting CICON24 to illuminate pioneering advances in cancer immunotherapy research starting September 8 in National Harbor, MD.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.cancerresearch.org\/media-room\/global-experts-converge-at-cicon24-to-unveil-groundbreaking-advances-in-cancer-immunotherapy-september-8-11-2024-at-national-harbor-md","og_locale":"es_ES","og_type":"article","og_title":"Global Experts Converge at CICON24 to Unveil Groundbreaking Advances in Cancer Immunotherapy, September 8-11, 2024 at National Harbor, MD - Cancer Research Institute","og_description":"CRI is co-hosting CICON24 to illuminate pioneering advances in cancer immunotherapy research starting September 8 in National Harbor, MD.","og_url":"https:\/\/www.cancerresearch.org\/media-room\/global-experts-converge-at-cicon24-to-unveil-groundbreaking-advances-in-cancer-immunotherapy-september-8-11-2024-at-national-harbor-md","og_site_name":"Cancer Research Institute","article_modified_time":"2024-09-06T16:15:43+00:00","og_image":[{"width":1080,"height":1080,"url":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2024\/09\/457019805_892139226283858_8428744184134729690_n-1.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Tiempo de lectura":"2 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.cancerresearch.org\/media-room\/global-experts-converge-at-cicon24-to-unveil-groundbreaking-advances-in-cancer-immunotherapy-september-8-11-2024-at-national-harbor-md","url":"https:\/\/www.cancerresearch.org\/media-room\/global-experts-converge-at-cicon24-to-unveil-groundbreaking-advances-in-cancer-immunotherapy-september-8-11-2024-at-national-harbor-md","name":"Global Experts Converge at CICON24 to Unveil Groundbreaking Advances in Cancer Immunotherapy, September 8-11, 2024 at National Harbor, MD - Cancer Research Institute","isPartOf":{"@id":"https:\/\/www.cancerresearch.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.cancerresearch.org\/media-room\/global-experts-converge-at-cicon24-to-unveil-groundbreaking-advances-in-cancer-immunotherapy-september-8-11-2024-at-national-harbor-md#primaryimage"},"image":{"@id":"https:\/\/www.cancerresearch.org\/media-room\/global-experts-converge-at-cicon24-to-unveil-groundbreaking-advances-in-cancer-immunotherapy-september-8-11-2024-at-national-harbor-md#primaryimage"},"thumbnailUrl":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2024\/09\/457019805_892139226283858_8428744184134729690_n-1.jpg","datePublished":"2024-09-06T16:12:31+00:00","dateModified":"2024-09-06T16:15:43+00:00","description":"CRI is co-hosting CICON24 to illuminate pioneering advances in cancer immunotherapy research starting September 8 in National Harbor, MD.","breadcrumb":{"@id":"https:\/\/www.cancerresearch.org\/media-room\/global-experts-converge-at-cicon24-to-unveil-groundbreaking-advances-in-cancer-immunotherapy-september-8-11-2024-at-national-harbor-md#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.cancerresearch.org\/media-room\/global-experts-converge-at-cicon24-to-unveil-groundbreaking-advances-in-cancer-immunotherapy-september-8-11-2024-at-national-harbor-md"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.cancerresearch.org\/media-room\/global-experts-converge-at-cicon24-to-unveil-groundbreaking-advances-in-cancer-immunotherapy-september-8-11-2024-at-national-harbor-md#primaryimage","url":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2024\/09\/457019805_892139226283858_8428744184134729690_n-1.jpg","contentUrl":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2024\/09\/457019805_892139226283858_8428744184134729690_n-1.jpg","width":1080,"height":1080},{"@type":"BreadcrumbList","@id":"https:\/\/www.cancerresearch.org\/media-room\/global-experts-converge-at-cicon24-to-unveil-groundbreaking-advances-in-cancer-immunotherapy-september-8-11-2024-at-national-harbor-md#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.cancerresearch.org\/es"},{"@type":"ListItem","position":2,"name":"Media Room Article","item":"https:\/\/www.cancerresearch.org\/media-room"},{"@type":"ListItem","position":3,"name":"Global Experts Converge at CICON24 to Unveil Groundbreaking Advances in Cancer Immunotherapy, September 8-11, 2024 at National Harbor, MD"}]},{"@type":"WebSite","@id":"https:\/\/www.cancerresearch.org\/#website","url":"https:\/\/www.cancerresearch.org\/","name":"Cancer Research Institute","description":"For a World Immune to Cancer","publisher":{"@id":"https:\/\/www.cancerresearch.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cancerresearch.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/www.cancerresearch.org\/#organization","name":"Cancer Research Institute","url":"https:\/\/www.cancerresearch.org\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.cancerresearch.org\/#\/schema\/logo\/image\/","url":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/05\/logo-gradient.svg","contentUrl":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/05\/logo-gradient.svg","width":156,"height":53,"caption":"Cancer Research Institute"},"image":{"@id":"https:\/\/www.cancerresearch.org\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/cri_news\/32406","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/cri_news"}],"about":[{"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/types\/cri_news"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/media\/32407"}],"wp:attachment":[{"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/media?parent=32406"}],"wp:term":[{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/tags?post=32406"},{"taxonomy":"resource_cancer_types","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/resource_cancer_types?post=32406"},{"taxonomy":"resource_patient_age","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/resource_patient_age?post=32406"},{"taxonomy":"resource_cancer_stage","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/resource_cancer_stage?post=32406"},{"taxonomy":"resource_treatment_type","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/resource_treatment_type?post=32406"},{"taxonomy":"resource_treatment_status","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/resource_treatment_status?post=32406"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}